Jennifer Shanley

Special Counsel

Jennifer provides health regulatory counsel to a range of industry clients, including pharmaceutical, biologic, and medical device manufacturers, digital health providers, clinical laboratories, pharmacies, health systems, hospitals, provider practice groups, skilled nursing facilities, home care agencies, health insurers, charitable foundations and companies that support or invest in the health industry.

Download full bio 


  • Structure Therapeutics – $185.3 Million IPO 

  • Apollo Endosurgery to Be Acquired by Boston Scientific 

  • CinCor Pharma to Sell to AstraZeneca for Approximately $1.8 Billion 

  • Sixth Street Invests in Blueprint Medicines 

  • Bristol Myers Squibb to Acquire Turning Point Therapeutics for $4.1 Billion 

  • View all


  • Fordham University School of Law
    JD, 2010

  • Georgetown University
    BS, Health Care Management and Policy (Major), International Health (Certificate)
    magna cum laude, 2007

Admissions & Credentials

New York

New Jersey

Rankings & Accolades

    Best Lawyers: Ones to Watch in Healthcare Law (2021-2022)